Evidence map›Paper›PMID 41273690›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

The Alkaline Comet Assay for Assessment of DNA Damage.

Mahima Bajpayee, Alok Dhawan

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mahima BajpayeeDepartment of Toxicology, MDR Laboratories Pvt. Ltd., Chennai, Tamil Nadu, India.
Alok DhawanCentre for BioMedical Research, Lucknow, Uttar Pradesh, India. alok.dhawan@cbmr.res.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anthropogenic activities, indiscriminate and rapid industrialization, as well as pursuance of a comfortable lifestyle have led to an increase in the use of industrial chemicals, pesticides, fossil fuels, polymers, new chemical entities, engineered nanomaterials, and nanocomposites. This has increased environmental pollution leading to adverse impact on all living beings including humans. Sensitive and robust test systems are thus required for accurate hazard identification and risk assessment. The Comet assay has been used widely as a simple, rapid, and sensitive tool for assessment of DNA damage in single cells from both in vitro and in vivo models as well as in humans. The advantages of the in vivo Comet assay are its ability to detect DNA damage in both proliferating or non-proliferating cells and its sensitivity to detect genotoxicity. The recommendations from the international workshops held for the Comet assay have established guidelines, and OECD has also adopted a guideline for the in vivo Comet assay as a test for assessing DNA damage in animals. The in vitro Comet assay conducted in cultured cells can be used for screening large number of compounds and at very low concentrations. The in vitro assay has also been automated to provide a high-throughput screening method for new chemical entities, as well as in environmental samples. This chapter details the in vitro Comet assay using the 96-well plate and in vivo Comet assay in multiple organs of the mouse.

Indexed as

Comet AssayDNA DamageAnimalsHumansMiceAlkaline Comet assayChinese hamster ovary cellsDNA damageGenotoxicityIn vitroIn vivoMouse multiple organs

Identifiers

PMID41273690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.